GlucoTrack Inc (NASDAQ: GCTK)’s stock price has gone rise by 8.90 in comparison to its previous close of 0.36, however, the company has experienced a 8.77% increase in its stock price over the last five trading days. globenewswire.com reported 2025-03-19 that Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conference Safety and performance data from direct blood glucose measurement technology to be featured at international diabetes technology conference
Is It Worth Investing in GlucoTrack Inc (NASDAQ: GCTK) Right Now?
Company’s 36-month beta value is -0.24.
The public float for GCTK is 10.17M, and currently, short sellers hold a 7.74% ratio of that floaft. The average trading volume of GCTK on March 20, 2025 was 3.87M shares.
GCTK’s Market Performance
The stock of GlucoTrack Inc (GCTK) has seen a 8.77% increase in the past week, with a -14.25% drop in the past month, and a -92.46% fall in the past quarter. The volatility ratio for the week is 11.03%, and the volatility levels for the past 30 days are at 14.16% for GCTK. The simple moving average for the past 20 days is 8.54% for GCTK’s stock, with a -98.43% simple moving average for the past 200 days.
GCTK Trading at -63.18% from the 50-Day Moving Average
After a stumble in the market that brought GCTK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.61% of loss for the given period.
Volatility was left at 14.16%, however, over the last 30 days, the volatility rate increased by 11.03%, as shares sank -7.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -93.36% lower at present.
During the last 5 trading sessions, GCTK rose by +8.77%, which changed the moving average for the period of 200-days by -99.06% in comparison to the 20-day moving average, which settled at $0.3587. In addition, GlucoTrack Inc saw -94.78% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GCTK starting from SYCOFF DREW, who purchase 182,540 shares at the price of $1.26 back on Apr 22 ’24. After this action, SYCOFF DREW now owns 2,951,258 shares of GlucoTrack Inc, valued at $230,000 using the latest closing price.
Stock Fundamentals for GCTK
Current profitability levels for the company are sitting at:
- -157.33 for the present operating margin
- 0.21 for the gross margin
The net margin for GlucoTrack Inc stands at -355.12. The total capital return value is set at 1.75. Equity return is now at value -1943.32, with -371.90 for asset returns.
Based on GlucoTrack Inc (GCTK), the company’s capital structure generated -1.28 points at debt to capital in total, while cash flow to debt ratio is standing at -5.06.
Currently, EBITDA for the company is -7.09 million with net debt to EBITDA at -0.15. When we switch over and look at the enterprise to sales, we see a ratio of 141.97. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.14.
Conclusion
In a nutshell, GlucoTrack Inc (GCTK) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
